Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2020

Jan 2, 2020

34301_dirs_2020-01-02_5ff7be96-3ee7-4edc-9e38-5cec97fa9bf1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2020-01-01

Reporting Person: van Es-Johansson An (Director)